Lonza is a multinational Swiss company that operates in the field of life sciences and specialized chemical manufacturing. It is one of the leading global suppliers in the pharmaceutical, biotechnology, and personal care industries. The company provides a wide range of products and services, including custom manufacturing, research and development, and contract development and manufacturing organization (CDMO) services.
In the pharmaceutical sector, Lonza offers solutions for drug substance and drug product development, as well as clinical and commercial manufacturing of active pharmaceutical ingredients (APIs). They have expertise in small molecules, peptides, and biologics, with a focus on innovative technologies and processes.
In the biotechnology field, Lonza specializes in cell and gene therapy manufacturing, offering solutions for the production of viral vectors, gene-modified cell therapies, and stem cell research. They assist customers in overcoming manufacturing challenges, from process development to commercial-scale production.
Furthermore, Lonza provides a vast range of specialty chemicals for various industries, including personal care, agrochemicals, nutrition, and coatings. Their expertise in chemical synthesis and formulation enables the development of unique and high-quality products to meet customer demands.
Overall, Lonza is a global leader in the life sciences industry, offering a comprehensive range of products and services to support the development and manufacturing needs of pharmaceutical, biotechnology, and personal care companies.
